2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1977

Impact of Ultrasound in Treatment Decision of Rheumatoid Arthritis Assessed in Routine Clinical Practice
Abstract Number: 2076

Impact of Vasculitis on Employment and Income: An Online Survey of Participants in the Rare Diseases Clinical Research Network – Vasculitis Clinical Research Consortium Patient Contact Registry
Abstract Number: 90

Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis
Abstract Number: 1511

Impacts of Disease Activity and Serum Level of Neurotrophic Factors on Depression in Rheumatoid Arthritis
Abstract Number: 819

Impaired Adiponectin Signaling in SSc Contributes to Myofibroblast Differentiation and Organ Fibrosis
Abstract Number: 2671

Impaired Bone Health in Patients with Primary Sjogren’s Syndrome
Abstract Number: 474

Impaired Cognition Is Linked to Brain Depletion in Brain-Derived Neurotrophic Factor Levels in a Rat Model of Rheumatoid Arthritis
Abstract Number: 271

Impaired Satellite Cell Activation and Myofiber Transition during Skeletal Muscle Regeneration in Patients with Polymyositis and Dermatomyositis
Abstract Number: 2504

Impaired Vasodilator Function in Rheumatoid Arthritis Patients Who Flared Due to Stopping Adalimumab or Etanercept
Abstract Number: 1148

Implementation of a Gout Knowledge Based Assessment Tool in an Inter-Professional, Multi-Disciplinary Musculoskeletal Training Program
Abstract Number: 1152

Implementation of a Musculoskeletal Ultrasound Teaching Program Is Not Determined By Fellowship Program Size
Abstract Number: 2509

Implementation of the Treat to Target Concept in Evaluation of Rheumatoid Arthritis Patients
Abstract Number: 3214

Implementation of Treat to Target in Rheumatoid Arthritis through a Learning Collaborative
Abstract Number: 1263

Implicit Biases Influencing Service Provision in Physical Therapy for Low Back Pain
Abstract Number: 530

Importance of Functional and Utility Evaluation on Disease Activity Level in Rheumatoid Arthritis: Interrelations and Predictive Value

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].